T1	Participants 31 58	non-small cell lung cancer:
T2	Participants 76 122	patients with or without nodal micrometastases
T3	Participants 278 319	patients with non-small cell lung cancer.
T4	Participants 740 772	Lymph nodes from patients (n=94)
T5	Participants 2075 2137	patients without an early locoregional spread of cancer cells.
